As a FHITH96N mutant protein binds Ap3A efficiently, but has a strong catalytic defect, and nevertheless maintains the anti‐tumor capabilities of FHIT (Siprashvili et al., 1997), the leading hypothesis has been that FHIT bound to its substrate constitutes the active tumor suppressor signaling unit. The gene discussed is FHIT; the disease is neoplasm.